Ala. Admin. Code r. 540-X-26-.05

Current through Register Vol. 43, No. 1, October 31, 2024

Section 540-X-26-.05 - [Effective until 11/14/2024] Limitations

(1) The scope of an Agreement shall NOT include:

(a) Any person or patient of a Collaborating Physician for whom such Collaborating Physician has not prepared a patient-specific, drug- or drug class-specific, disease-specific, or condition-specific plan of care based on a physical examination of the patient by the Collaborating Physician within the past twelve (12) months, with the exception of immunizations and acute, uncomplicated illness or injury as well as the dispensing of opioid antagonists as defined in Ala. Code § 20-2-280; or

(b) The prescribing of controlled substances listed or to be listed in the schedules under federal law and in Ala. Code §§ 20-2-23, 20-2-25, 20-2-27, 20-2-29, and 20-2-31 and/or Ala. Admin. Code r. 420-7-2 and its Appendix.

(2) No retail pharmacy may employ a physician for the purpose of maintaining, establishing, or entering into a collaborative practice agreement. Nothing shall prohibit a retail pharmacy from hiring a physician or licensed medical practitioner for the purpose of conducting quality assurance reviews of its pharmacists that are engaged in the practice of collaborative drug therapy.

Ala. Admin. Code r. 540-X-26-.05

Adopted by Alabama Administrative Monthly Volume XXXIX, Issue No. 11, August 31, 2021, eff. 10/15/2021.

Amended by Alabama Administrative Monthly Volume XLII, Issue No. 02, November 30, 2023, eff. 1/14/2024.

Author: Alabama Board of Medical Examiners

Statutory Authority:Code of Ala. 1975, § 34-24-53; Act 2019-368 (Code of Ala. 1975, § 34-23-77).